Elan announced a series of transactions designed to transform the... 
Vortioxetine clinical phase III data show significant improvement in... 
XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen... 
Special Reports
Pharmalot
Here is a question that is likely to plague the pharmaceutical industry and patient advocacy groups for some time to...
Good morning, everyone, and how are you today? We hope you are feeling refreshed and energized, because the weekend is...
Like a game of whack-a-mole, no matter how many times Johnson & Johnson attempts to put to rest lawsuits over the...
5
Our experts are on hand to offer industry-specific advice.
Business
- Community Oncology Organizations, Clinics and Patients Support the Bipartisan 'Preserve Community Cancer Care Act'
- BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute
- TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace
Marketing & Advertising
- Community Oncology Organizations, Clinics and Patients Support the Bipartisan 'Preserve Community Cancer Care Act'
- BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute
- TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace
Therapeutics
- Community Oncology Organizations, Clinics and Patients Support the Bipartisan 'Preserve Community Cancer Care Act'
- BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute
- TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace
R&D
- Community Oncology Organizations, Clinics and Patients Support the Bipartisan 'Preserve Community Cancer Care Act'
- BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute
- TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace